Skip to main content
SNOA logo

SNOA

Sonoma Pharmaceuticals, Inc.
$1.23 -0.02 (-1.60%) At close · Jul 7
Market Cap
$5.89M
Shares
4,785,801

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$19.53M +36.7%
FY2026 Revenue FY2011–FY2026
Net Income
-$3.18M +8.2%
FY2026 Net Income FY2011–FY2026
Gross Margin
37.97% -0.3pp
FY2026 Gross Margin FY2011–FY2026
Operating Margin
-12.6% +13.4pp
FY2026 Operating Margin FY2011–FY2026
Diluted EPS
-$1.89 +32.3%
FY2026 Diluted EPS FY2014–FY2026
Operating Cash Flow
-$3.93M -4369.3%
FY2026 Operating Cash Flow FY2011–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2012 FY2011
$19.53M $14.29M $12.74M $13.27M $12.63M $18.63M $18.94M $18.97M $16.66M $12.83M $15.08M $13.85M $13.67M $15.45M $12.74M
$16K -$10K
$12.11M $8.82M $7.99M $8.8M $8.64M $12.07M $10.6M $10.09M $9.35M $7.16M $7.87M $6.57M $5.27M $4.71M $4.03M
$7.42M $5.47M $4.75M $4.48M $3.99M $6.56M $8.33M $8.88M $7.31M $5.67M $7.21M $7.29M $8.4M $10.74M $8.71M
37.97% 38.25% 37.26% 33.73% 31.62% 35.21% 44.01% 46.81% 43.88% 44.19% 47.8% 52.61% 61.44% 69.52% 68.38%
$2.27M $1.81M $1.87M $207K $125K $555K $1.34M $1.52M $1.58M $1.58M $1.81M $1.53M $2.89M $2.22M $1.98M
$7.61M $7.36M $7.58M $8.84M $9.76M $9.45M $13.67M $18.62M $19.92M $17.07M $15.56M $12.41M $11.56M $11.89M $13.2M
$139K $138K $176K $125K $186K $227K $312K $453K $490K $248K $244K $253K $284K $268K $326K
$9.88M $9.18M $9.45M $9.05M $9.88M $10.01M $15M $20.14M $21.5M $18.64M $17.36M $13.95M $14.45M $14.12M $15.18M
-$2.46M -$3.71M -$4.7M -$4.57M -$5.89M -$3.45M -$6.67M -$11.26M -$14.19M -$12.97M -$10.15M -$6.66M -$6.05M -$3.37M -$6.47M
-12.6% -25.97% -36.91% -34.43% -46.62% -18.51% -35.23% -59.35% -85.18% -101.16% -67.3% -48.07% -44.27% -21.84% -50.75%
-$2.32M -$3.57M -$4.53M -$4.45M -$5.7M -$3.22M -$6.36M -$10.81M -$13.7M -$12.73M -$9.91M -$6.41M -$5.77M -$3.11M -$6.14M
$13K $12K $16K $33K $40K $3000 $3000 $3000 $1.06M $1.11M $931K
$16K $50K $190K $258K $22K $2000 $1000 $1000 $7000 $4000
$0 -$4.65M
-$3.42M -$2.91M -$5.03M -$5.18M -$5.42M -$3.9M -$2.83M -$11.34M -$14.33M -$12.94M
-$244K $550K -$196K -$33K -$332K $713K $121K $458K $0 -$4.27M $0 $0 $0 -$391K
-$3.18M -$3.46M -$4.84M -$5.15M -$5.09M -$3.95M -$2.95M -$11.8M -$14.33M $9.27M -$10.16M -$8.2M $3.74M -$5.43M -$7.33M
-16.26% -24.2% -37.97% -38.81% -40.28% -21.2% -15.56% -62.19% -86.01% 72.31% -67.37% -59.21% 27.33% -35.15% -57.51%
-$8.2M $3.74M -$6.49M
-$8.64M $3.66M -$5.37M -$7.48M
USD/shares -$1.89 -$2.79 -$10.60 -$30.40 -$17.00 $10.80
USD/shares -$1.89 -$2.79 -$10.60 -$30.40 -$17.00 $10.80
shares 1.68M 1.24M 454.5K 169.7 99.8K 73.85K 46.2K 226.5K 211.2K 822.2 482.85K 344.1K 248.85 1.37M
shares 1.68M 1.24M 454.5K 169.7 99.8K 73.85K 46.2K 226.5K 211.2K 822.2 482.85K 344.9K 248.85 1.37M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Shipping And Handling $180,000 $18,000 $28,000 $42,000 $52,000 $37,000
Product $13,732,000 $12,313,000 $11,926,000 $12,179,000 $18,517,000
Service $1,346,000 $449,000 $112,000
Key facts CIK 1367083 CUSIP 83558L303 Visit website Investor relations